ArticleJournal for immunotherapy of cancer2016
Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy.
Hasan Rehman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
207 papers cite itlatest 60 shown
this paperpooled ittrialcites it